Skip to main content
Download PDF

The total polyphenolic glycoside extract of Lamiophlomis rotata ameliorates hepatic fibrosis through apoptosis by TGF-β/Smad signaling pathway

Chinese Medicine volume 18, Article number: 20 (2023) Cite this article

Abstract

Background

Hepatic fibrosis is characterized by the excessive deposition of extracellular matrix (ECM) which is mainly secreted by activated hepatic stellate cells (HSCs). Lamiophlomis rotata (L. rotata) was recorded to treat jaundice in the traditional Tibetan medical system with the potential of hepatoprotection. However, the bioactivities and the possible mechanism of L. rotata on hepatic fibrosis is still largely unknown.

Aim of the study

To investigate the anti-hepatic fibrosis effects of bioactivities in L. rotata and the probable mechanism of action.

Materials and methods

Herein, total polyphenolic glycosides of L. rotata (TPLR) was purified with the selectivity adsorption resin and was analyzed by ultrahigh-performance liquid chromatography coupled with time-of-flight mass spectrometry (UPLC-Q/TOF/MSn). The anti-hepatic fibrosis effect of TPLR was evaluated by carbon tetrachloride (CCl4)-induced liver fibrosis, and was evaluated with the apoptosis of activated HSCs.

Results

In total, sixteen compounds, including nine phenylpropanoids and six flavonoids, were identified in the UPLC-TOF-MSn profile of the extracts. TPLR significantly ameliorated hepatic fibrosis in CCl4-induced mice and inhibited HSCs proliferation, Moreover, TPLR notably increased the apoptosis of activated HSCs along with up-regulated caspase-3, -8, -9, and -10. Furthermore, TPLR inhibited TGF-β/Smad pathway ameliorating hepatic fibrosis though downregulation the expression of Smad2/3, Smad4, and upregulation the expression of Smad7 in vivo and in vitro. Simultaneously, the expression of fibronectin (FN), α-smooth muscle actin (α-SMA), and Collagen I (Col1α1) were decreased in tissues and in cells with TPLR administration.

Conclusion

These results initially demonstrated that TPLR has the potential to ameliorate hepatic fibrosis through an apoptosis mechanism via TGF-β/Smad signaling pathway.

Graphical Abstract

Highlights

  • Chemical composition of TPRL was identified by UPLC-Q/TOF/MSn in the profile of total ion current.

  • TPRL was initially demostrated the effects of anti-hepatic fibrosis in vitro and in vivo.

  • TPRL ameliorates hepatic fibrosis through apoptosis by TGF-β/Smad signaling pathway.

Introduction

Liver fibrosis is an abnormal hyperplasia of liver connective tissue defined as excess deposition of ECM in response to various liver damages and ultimately progresses to decompensated cirrhosis or hepatocellular carcinoma (HCC) with limited therapeutic options [1]. Activated HSCs are the key effectors of fibrogenesis through increased deposition of fibrillar ECM which negatively affects the regeneration of the liver parenchyma [2, 3]. In the recovering liver, apoptosis is orchestrated by complex interactions between pro-apoptotic and pro-survival signals in activated HSCs, where about 50% of activated HSCs undergo apoptosis [4]. Apoptosis of activated HSCs is a mechanism of cellular recycling and homeostasis that contributes to the spontaneous resolution of liver fibrosis [5, 6]. Nowadays, studies have been conducted to elucidate the molecular mechanisms and the central elements of HSC apoptotic pathways, and different drugs focused on investigations for the activation of apoptosis on HSCs and that needs further studies [7,8,9].

Recent literature has been conducted to elucidate the molecular mechanisms of natural products on activation and apoptosis of HSCs [10,11,12]. Aside from caspase, Fas, and TNF-related apoptosis-inducing ligand (TRAIL) pathways, the transforming growth factor-β (TGF-β) signaling is also responsible for regulating HSC apoptosis in the hepatic fibrosis model [13]. TGF-β1-activated HSCs are resistant to apoptosis, and apoptosis resistance aids in maintaining the profibrotic environment and sustains the presence of activated HSCs [14, 15]. Conversely, inhibition of the TGF-β1 signaling pathway substantially promotes the apoptosis of HSCs and ameliorates hepatic fibrosis. For example, Smad7, a negative regulator of Smad signaling involving TGF-β, disrupted cell apoptosis by blocking the binding of TGF-β receptors of Smad2/3 [16]. Additionally, TGF-β1 is one of the most effective cytokines for the transformation and proliferation of HSCs with the upregulation of α-SMA, COL1α1 and FN [17]. Therefore, it is prospective to find compounds or extracts which promote the apoptosis of HSCs through inhibition TGF-β/Smad signaling pathway against hepatic fibrosis in traditional Chinese medicine.

Lamiophlomis rotata (L. rotata), an orally available Tibetan herb, is known as “Daba” or “Dabuba” in Jingzhubencao (Qing Dynasty, AD 1848) and as “Duyiwei” in the Chinese Pharmacopoeia [18]. According to traditional Tibetan medical system, the herb was used to treat “yellow-water disease” such as skin disease, rheumatism, and jaundice with low toxicity for thousands of years [19]. Pharmacological studies found that L. rotata has a wide range of activities including analgesic, anti-nociceptive, haemostatic, and anti-inflammatory effects about neuropathic pain, rheumatoid arthritis, and traumatic injury symptoms, while few of these have been concerned to the active ingredients with hepatoprotective effects about jaundice [18, 19]. Fortunately, the aqueous extract of the herb showed hepatoprotective effects with efficiently reduced the levels of AST, ALT in rats [20]. Furthermore, the aqueous extract of L. rotata has been demonstrated against hepatic fibrosis in vivo [21]. However, it is still poor knowledge about which kind of extracts or compounds in L. rotata are responsible for the effects of anti-hepatic fibrosis, and the probable mechanism of the action still remains largely unknown.

Phytochemical studies on L. rotata have identified 223 chemical constituents including phenylpropanoids and flavonoid glycosides (also known as polyphenolic glycoside), iridoids, and volatile oils, in which iridoids and polyphenolic glycosides are considered the main characteristic constituents of L. rotata [19]. Our previous study confirmed that iridoid glycosides of L. rotata accelerated the secretion of ECM in human dermal fibroblast during the progression of wound healing [22]. Moreover, polyphenolic glycoside extracts have been reported with hepatoprotective effects in Cistanche deserticola [23], Forsythia suspensa [24], and Lespedeza cuneate [25], these results implied that polyphenolic glycosides (including phenylpropanoids and flavonoid glycosides) of L. rotata might exert antifibrotic effects. Here, the polyphenolic glycosides extract of L. rotata (TPLR) was purified with the selectivity adsorption resin, and was analyzed by UPLC-Q/TOF/MSn, experiments were designed to investigate whether TPLR could ameliorate hepatic fibrosis and promote the apoptosis of HSCs by inhibiting the TGF-β/Smad signaling pathway in vivo and in vitro. The study would be beneficial to exploration bioactivities of L. rotata against hepatic fibrosis through TGF-β/Smad signaling pathway in traditional Tibetan medicine.

Materials and methods

Chemical and regents

Serum aspartate aminotransferase (AST), the alanine aminotransferase (ALT) and hydroxyproline (Hyp) were manufactured by Jiancheng Bioengineering Institute (Nanjing, China). Anti-αSMA, anti-COL1α1, anti-FN and anti-TGF-β1were brought from Servicebio (Wuhan, China). CCK-8 kit was purchased from Dojindo Laboratories (Kumamoto, Japan). Penicillin and streptomycin, Dulbecco’s modified Eagle’s medium (DMEM) media and FBS were brought form Gibco (Carlsbad, USA). The Annexin V/PI Cell Apoptosis Detection Kit was brought from BD (Pharmingen, USA). RIPA lysis buffer (p0013B), phenylmethanesulfonyl fluoride (PMSF), BCA protein assay kit, SDS-PAGE and EdU Cell Proliferation Kit were got from Beyotime (Beijing, China). 0.25 μm polyvinylidene fluoride membranes (PVDF) were brought from Millipore (Bedford, Massachusetts). Skim milk was provided by Sangon Biotech (Shanghai, China). Primary antibodies against GAPDH, Smad2/3, Smad2, caspase-8, -9, -3 were from Cell Signaling Technology (Boston, USA), primary antibodies against β-actin and Smad7 were purchased from Proteintech (Wuhan, China). Primary antibody against caspase-10 was brought from GeneTex SAN Antonio (Texas, USA). TGF-β1 was purchased from PeproTech (Suzhuo, China) and used at a concentration of 10 ng/ml. TRIzol Reagent (Takara, JAPANES), MonScript™ RTIIIAll-in-One Mix with dsDNase (Monad Biotech, Wuhan, China), and GoTaq® qPCR Master Mix (Promega, USA) were used in RT-qPCR. All other chemicals were commercially available and used without further purification.

Plant materials and sample preparation

The aerial parts of L. rotata (2.4 kg) were collected in Gansu provinces of China. The herbs were authenticated by Professor Yi Zhang (Chengdu University of Traditional Chinese Medicine, Chengdu, China), and were dried in the shade, voucher specimens were deposited at the College of Ethnic Medicine (Chengdu University of Traditional Chinese Medicine, Chengdu, China). The sample was extracted and purified as reported elsewhere [26]. Briefly, the sample was extracted three times with refluxing 70% EtOH, the solvent was removed under reduced pressure, the residue solution was adsorbed and purified by polyamide resin, and the 85% ethanolic elution was removed under reduced pressure and the resulting extract (101.8 g) was the total polyphenolic glycosides extract of L. rotata. Samples of suitable concentration (0.1 g/mL) were stored at -4 °C for further analysis. The sample solutions were filtered through a 0.22 -µm pore size nylon membrane filter before injection into the UPLC.

UPLC-MS / MSn analysis

UPLC-MS/MSn analysis was performed according to the method described in our previous studies [27]. The difference between the referential method was the mobile phases system, in this study, the mobile phases were (a) water with 0.1% (v/v) formic acid and (b) methanol with 0.1% (v/v) formic acid, and the optimized elution conditions were as follows: holding at 15% B for 2 min, a linear gradient from 20 to 72% B (2 to 30 min), and then back to15% B in 1 min. The flow rate was 0.3 mL/min. The column temperature was 35 ℃, and the injection volume was 2 µL.

Animals and treatment

Fifty mice were randomly distributed into five groups (n = 10), mice in control group were injected with olive oil, other mice were injected with 10% CCl4 in olive oil (0.5 ml/kg) twice a week for 8 weeks to induce liver fibrosis [28]. According to the yield of the TPLR preparation and the usual clinical doses for the granule preparation of L. rotata [21], the dosages of TPLR in different groups were 50, 100 and 200 mg/kg (equal to 1.0, 2.0 and 4.0 g /kg of raw material). Fourth week after the modeling, each group were orally administered with or without TPLR dissolved in 0.5% sodium carboxymethyl-cellulose (CMC-Na) for 6 weeks.

Serum aminotransferase and hepatic hydroxyproline measurements

The levels of ALT, AST, and Hyp in the serum were measured by the instructions of manufacturer (Nanjing Jiancheng Bioengineering Research Institute, Nanjing, China).

Morphology and immunofluorescence staining

The harvested liver tissues were soaked in 4% polyformaldehyde dehydrated with an ethanol gradient, embedded in paraffin, and the paraffin tissue Sects. (5 µm) were stained with hematoxylin and eosin (HE), Masson, Sirius red and immunofluorescence (IF). Liver morphology and IF were performed as reported elsewhere [29]. Briefly, the liver sections were dewaxed, rehydrated, and placed in 1× citrate buffer (Thermo Fisher Scientific, Shanghai, China) for high pressure antigen repair over 5 min. The sections were then allowed to cool naturally. After the liver tissues were blocked with 5% BSA for 1 h, then incubated with TGF-β1 (1:200), α-SMA (1:500), COL1α1 (1:500), FN (1:200) at 4 °C overnight. After three washes with PBS, the corresponding secondary antibodies (Life Technologies, USA) were applied at a dilution of 1:200 in 1% BSA and incubated with the sections for 1 h at room temperature. Sections were subsequently counter-stained with DAPI for 5 min to visualize nuclei. Images were captured using a Nikon confocal microscope (Nikon, Tokyo, Japan). Three to five fields were randomly selected from each slide, and the proportions of the positive areas or cells in each field were determined using Image J (Media Cybernetics, Silver Springs, MD, USA).

Cell culture and treatment

The human hepatic stellate cell line LX-2 and the rat hepatic stellate HSC-T6 cell line were purchased from Fu Heng Cell Center (Shanghai, China and used for in vitro experimental validation. L929 cells, the fibroblast of mice, were brought from Jennio Biological Technology company (Shanghai, China) and applied for cytotoxicity assessments. They were propagated in DMEMmedia supplemented with 10% FBS, 1% penicillin and streptomycin at 37 °C in a humidified atmosphere of 95% air and 5% CO2, and all of them were cultured in 10 cm dishes, all cells were cultured until 80% confluent and then used in further applications.

Cell viability assay

The cell viability and cytotoxicity assessments of different concentrations 0, 10, 25, 50, 100 and 200 μg/mL of TPLR dissolved in 0.2% DMSO was evaluated using the CCK-8 assay, as reported elsewhere [30]. Briefly, the cells were assayed in 96‐well plates at 5000 cells per well by CCK-8 kits and treated with TPLR for 48 h in medium containing 10% serum. After incubation of the cells, viable cells were stained with CCK-8 (10 µl, 3.5 h). Absorbance was measured at 450 nm using a multimode microplate reader (Tecan, Research Triangle Park, USA).

Edu staining

Cell proliferation was detected by EdU Cell Proliferation Kit. LX-2 cells with 0, 50, 100 and 200 μg/ml TPLR, respectively, for 48 h. Then, 10 µmol/L EdU were added into cells for 2.5 h followed by washing with pre-cooled PBS. After incubating, LX-2 cells were fixed and permeabilized with 0.1% Triton. Click Additive Solution was incubated for 30 min at room temperature shielded from light [31]. The images were taken by fluorescence microscopy under an optical microscope at 200 × .

Flow cytometry analysis

LX-2 cells were treated with consecutive concentrations of TPLR for 48 h. Besides, LX-2 cells were treated with or without 10 ng/mL TGF-β1 12 h, and then incubated with 0, 100 and 200 μg/mL TPLR for 12 h [33]. After incubated for the indicated time, the cells were digested by trypsin without ethylene diamine tetraacetic acid (EDTA), washed with PBS and stained with the Annexin V/PI Cell Apoptosis Detection Kit (BD, Pharmingen, USA), as reported elsewhere [32]. Fluorescence-activated cell sorting (FACS) analysis was acquired from cytometry (BD, California, USA) to analyze the apoptotic cells.

Real-Time quantitative PCR

The concentration of RNA was determined by absorption measurements at 260/280 nm using a UV–visible spectrophotometer (Bio-Rad, USA). Total RNA was extracted from LX-2/HSC-T6 cells and liver tissue using TRIzol Reagent, and the cDNA was synthesized using MonScript™ RTIIIAll-in-One Mix with dsDNase, from 0.3 μg RNA for each sample. Real-time PCR was performed using a GoTaq® qPCR Master Mix as follows: 10 μL reaction solution contained 5 μL SYBR Mix, 0.2 μL sense and 0.2 μL antisense primers solution (from 10 μM), 1 μL diluted cDNA, and 3.2 μL nuclease-free water. Primer sequences of all selected genes are shown in the Additional file 1: Table S1. The results were quantified using the 2−ΔΔCt method.

Western blot assay

Liver tissues and LX-2 cells were washed three times with ice-cold PBS and lysed in 100 to 300 μl RIPA lysis buffer (p0013B) supplemented with 1% PMSF [32]. The supernatants of cell lysates were collected by centrifugation at 12,000 × g for 10 min at 4 °C, and total protein concentration was measured using the BCA protein assay kit. The extracted proteins were separated by polyacrylamide 8%-12% SDS-PAGE (concentrated gel voltage was 80 V, separated gel voltage was 120 V); and electrophoretically transferred onto 0.25 μm PVDF; use 5% skim milk to block the PVDF for 1 h at room temperature. After washing the membrane with TBST, incubate with the following antibodies at 4 °C in a shaker overnight, GAPDH, Caspase-3, -8, -9, -10, Smad2/3, and Smad4 (1: 1000), β-actin (1: 10,000), Smad7 (1: 500).

Data analysis

The software of GraphPad Prism 8.0 (GraphPad Software Inc., California, USA) was used for statistical analysis. Continuous variables were presented as mean ± standard deviation (SD). Statistical differences between groups were evaluated by one-way analysis of variance (ANOVA) followed by least significant difference (LSD) test. The differences were considered statistically significant when P value < 0.05.

Results

The total polyphenolic glycoside of L. rotata identified by UPLC- TOF-MSn spectra

The total polyphenolic glycoside extract of L. rotata (TPLR) was analyzed by MS and MSn in negative and positive ion mode. In total, 24 peaks were detected in the total ion current (TIC) profile of L. rotata (Fig. 1A). To identify the compounds, PubChem and SciFinder from the Scholar of the American Chemical Society were used to search for the spectral data of polyphenolic glycosides reported previously in the L. rotata and Lamium species, and the results were summarized in a spreadsheet (Excel, Microsoft, WA, USA). 22 compounds, including 10 phenylpropanoids and 9 flavonoids, were identified by comparing the retention times and mass spectra of the compounds to those of authentic standards (shown in Fig. 1B and Table 1).

Fig. 1
figure 1

The identification compounds in profile of total phenylpropanoid extract of L. rotata (TPLR) by UPLC-Q exactive mass spectrometer. A The total ion current in negative and positive mode of TPLR. B the chemical structures of compounds identified in TPLR

Full size image
Table 1 The identification compounds in total polyphenolic extract of L. rotata (TPLR) by UPLC-Q exactive mass spectrometer
Full size table

TPLR ameliorated hepatic injury and fibrosis

The effects of TPLR against hepatic injury and fibrosis were conducted with CCl4 induced hepatic fibrosis which described as reference [34]. The morphology examination of the liver tissue showed that model group with obvious nodular, irregular liver surface, and a wide range of small granular processes. In contrast to model group, TPLR treatment significantly ameliorated the state of fibrosis with tissue swelling (Fig. 2A). Microscopically, HE staining revealed that CCl4-induced mice had many fat tissue vacuoles, ballooning of hepatocytes and infiltration of inflammatory cells in the liver tissue, while TPLR exhibited strong efficacy against impaired hepatic tissue (Fig. 2B). Sirius Red and Masson Staining revealed that CCl4 injection resulted in connective tissue proliferation and fibrous collagen deposition in the mice liver; in contrast, TPLR reduced the fibrous area in a dose-dependent manner (Fig. 2C, D). Specially, the positive area of Sirius red staining was significantly decreased in the TPLR treatment groups, which suggested that TPLR down-regulated the expression of Collagen I (Col1α1) in liver (Fig. 2H) [35]. Furthermore, the result also showed that TPLR (100, 200 mg/kg) dramatically reduced the levels of ALT (Fig. 2E), AST (Fig. 2F), and Hyp (Fig. 2G). Altogether, these results clearly indicate the hepatoprotection and anti-hepatic fibrosis effects of TPLR.

Fig. 2
figure 2

TPLR ameliorated liver injury and reduced hepatic fibrosis in CCl4-induced mice. Representative morphology (A), HE (B), Sirius red (C) and Masson trichrome(D) staining of liver treatment with or without TPLR, the arrow points to the necrotic site, scale bars of HE, Sirius red staining: 100 μm; scale bars of Masson trichrome staining: 200 μm. The levels of ALT (E), AST (F) and Hyp (G) in serum with or without TPLR treatment. H The proportion area statistics of Sirius red. Data were shown as the mean ± SD (n = 6). #P < 0.05, vs. control group; *P < 0.05, **P < 0.01, vs. model group

Full size image

TPLR inhibited HSC cells viability and ECM secretion

The cytotoxic effects of TPLR on L929 cells were examined by CCK-8 assay [30]. The CCK-8 assay showed that in these concentrations, no significant cytotoxic effect of TPLR was obvious on L929 cells for 48 h (Fig. 3A). Since HSCs are critical for hepatic fibrogenesis, along with an increase in cell proliferation and oversecretion of extracellular matrix [36], two lines of HSC (LX-2 and HSC-T6 cells) was employed to measure the viability of TPLR on HSCs, TPLR significantly inhibited cell proliferation on LX-2 and HSC-T6 cells in a concentration-dependent manner (Fig. 3B, C), and the IC50 values were 140.8 and 78.12 μg/mL, respectively. Human cells, as opposed to rodent cells, are preferred for clarifying the mechanism of the antifibrotic drug, which could continuously maintain the in vivo phenotype [37, 38], we further investigated the effects of TPLR on proliferation in LX-2 by EdU staining, consistent with the results of CCK-8 assay, TPLR also showed the repression of proliferation on LX-2 cells with EdU staining (Fig. 3D, E). Moreover, in order to clarify the effect of TPLR on the ECM secretion of HSCs, we examined amplification of FN, COL1α1 and α-SMA in LX-2 and HSC-T6 cells by qPCR. Indeed, the mRNA levels of FN, COL1α1 and α-SMA were significantly down-regulated in LX-2 and HSC-T6 cells treated with 100 μg/mL TFLR for 48 h (Fig. 3F, G). These results indicated that TPLR inhibited the cells proliferation and ECM deposition both in LX-2 and HSC-T6 cells.

Fig. 3
figure 3

TPLR inhibited the proliferation and secretion on HSCs. The CCK-8 assay of the proliferation on A L929, B LX-2 and C HSC-T6 cells with different concentrations of TPLR (0, 10, 25, 50, 100 and 200 μg/ml) incubated for 48 h (n = 4). D The images of EdU staining on LX-2 cells with TPLR (0, 50, 100 and 200 μg/ml) for 48 h. In the representative EdU images, total cells stained with DAPI were blue, whereas proliferating cells were shown as red point, and the ratio of red in blue cells (n = 3), scale bars: 100 μm. E Quantitative analysis of EdU staining of proliferation on the LX-2 cells with different concentrations of TPLR treatment (n = 3) (F–G) The mRNA level of FN, Col1α1 and α-SMA in LX-2 cells with 100 μg/ml TPLR for 48 h. Data were shown as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 ****P < 0.0001, vs. control group

Full size image

TPLR promoted the apoptosis of LX-2 cells

To explore the possible mechanism of TPLR inhibiting the proliferation of LX-2 cells, we investigated the cell cycle and apoptosis the effect of HSCs with TPLR by flow cytometry. The flow cytometry results showed that TPLR had no obvious effect on the cell cycle (Additional file 1: Fig. S1), while TPLR significantly increased apoptotic rates of LX-2 cells in a dose-dependent manner at 48 h (Fig. 4A, B). Consequently, we verified the mechanisms of TPLR regulation the apoptosis in LX-2 cells by western blot, the results showed that concentration of TPLR (200 μg/mL) notably enhanced the expression of caspase-3, -8, -9 and -10 after treatment for 48 h (Fig. 4C, D). Since TGF-β1 also plays a vital contributory role in cellular functions such as cell growth, cell differentiation, and apoptosis [39]. We further investigated whether TPLR promoted the apoptosis of activated HSC with TGF-β1 by flow cytometry, the result showed that converse to TGF-β1 resisted apoptosis of LX-2 cells, TPLR significantly elevated the apoptosis rate of activated HSCs in 12 h (Fig. 4E, F). Correspondingly, apoptosis regulatory proteins were detected by western blot assay, as expected, TPLR treatment significantly increased the expression of caspase-3, -8, and -10 at 12 h, which belong to the extrinsic apoptosis subfamily; unexpectedly, TPLR barely raised the expression of caspase-9 (Fig. 4G, H) which the essential initiator caspase required for apoptosis signaling through the mitochondrial pathway [40]. In summary, the result suggested the effects of TPLR promoting the cells apoptosis was regulated by TGF-β1 which are resistant to intrinsic apoptosis pathway.

Fig. 4
figure 4

TPLR significantly induced the apoptosis on LX-2 cells. A The apoptosis effect of LX-2 cells with 0, 50, 100 or 200 μg/ml TPLR for 48 h by flow cytometry. B Quantitative analysis of A. C The levels of caspase-3, -8, -9, -10 after an incubation with various concentrations of TPLR (0, 50, 100 or 200 μg/ml) for 48 h by Western blot. D Quantitative analysis for western blotting (n = 3). The results are shown as mean ± SD; *P < 0.05, **P < 0.01, compared with the control group. E The apoptosis rates of LX-2 cells with TPLR (0, 100 or 200 μg/ml) for 12 h in the presence of TGF-β1 (10 ng/ml) for 12 h by flow cytometry. F Quantitative analysis of E. G The western blot results of the caspase family in LX-2 cells with TPLR (0, 50, 100 or 200 μg/ml) for 12 h with 10 ng/ml TGF-β1. H Quantitative analysis for western blotting (n = 3). The results are shown as mean ± SD; #P < 0.05, compared with the control group; *P < 0.05, **P < 0.01, ***P < 0.001 compared with the TGF-β1 group

Full size image

TPLR inhibited TGF-β/Smad signaling

TPLR down-regulated TGF-β/Smad signaling pathway in vitro

TGF-β1 also has been characterized as a critical mediator in the process of HSC activation [41], we further explore the mechanism of TPLR inhibited HSCs activation by target TGF-β/Smad signaling. Serum-starved LX-2 cells were treated with 10 ng/mL TGF-β1 for 12 h followed by TPLR for 12 h, the expression of Smad2/3 and Smad4 was increased by TGF-β1 treatment, and TPLR treatment significantly reversed this change (Fig. 5A–C). Meanwhile, the expression of Smad7, which is an antagonist of TGF-β/Smad signaling, was decreased with TGF-β1 stimulation in LX-2 cells, and TPLR treatment significantly increased the protein expression of Smad7 (Fig. 5A, D). Fortunately, similar changes were also observed at the mRNA levels of Smad2/3, Smad4 and Smad7 by qPCR (Fig. 5E–H). Altogether, these results indicated that TPLR notably restrained TGF-β/Smad signaling in vitro.

Fig. 5
figure 5

TPLR inhibited the TGF-β/Smad signaling pathway on LX-2 cells. A The protein levels of Smad2/3, Smad4, and Smad7 with TPLR (0, 100 and 200 μg/ml) for 12 h by Western blot. B–D Quantitative analysis for western blotting of B Smad2/3, C Smad4 and D Smad7 (n = 3). The mRNA levels of E Smad4, F Smad2, G Smad3, and H Smad7 with or without TPLR by qPCR (n = 3). Data were shown as mean ± SD. #P < 0.05, vs. control group; *P < 0.05, **P < 0.01, ****P < 0.0001 vs. TGF-β1 group

Full size image

TPLR down-regulated TGF-β/Smad signaling pathway in vivo

The progression and regression of hepatic fibrosis rely on a complex interplay of the hepatic microenvironment [42], to further explore whether TPLR inhibit the TGF-β/Smad signaling pathway under the internal environment, we examined the antifibrotic effect of TPLR on the CCl4-induced fibrotic mice, eight weeks after the repetitive injection of CCl4, proteins of Smad2/3 and Smad4 were significantly expressed, and Smad7 was obviously decreased in the model group. Compared to hepatic fibrotic mice, TPLR significantly down-regulated the protein expression levels of Smad2/3 and Smad4 and up-regulated Smad7 in a dose-dependent manner (Fig. 6A, )B). A hallmark of fibrosis is the overexpression of α-SMA and deposition of ECM, which mainly consists of Col1α1 and FN [43]. In this study, IF stains showed high levels of TGF-β1, α-SMA, COL1α1 and FN in the model group, whereas the deposition of extracellular matrix (ECM) was remarkably decreased in TPLR group (Fig. 6C-F). Further quantification of the mRNA levels in the tissue indicated that TGF-β1, α-SMA, COL1α1 and FN expression were significantly decreased compared to the control group (Fig. 6G). Based on these data, TPLR markedly decreased ECM deposition, ameliorated hepatic fibrogenesis by downregulating TGF-β/Smad signaling pathway in the hepatic tissue.

Fig. 6
figure 6

TPLR downregulated TGF-β/Smad signaling pathway in mice. A The expressions of Smad4, Smad2/3 and Smad7 in liver with or without TPLR treatment by western blotting. B Quantitative analysis for western blotting of Smad2/3, Smad4 and Smad7 (n = 3). C Dual immunofluorescence staining for TGF-β1 (green) and α-SMA (red) in mice liver tissues with or without TPLR treatment. scale bar, 20 μm. D Quantitative analysis of C. E Dual immunofluorescence staining for Col1α1(green) and FN (red) in mice liver tissues with or without TPLR treatment. scale bar, 20 μm. F Quantitative analysis of E. Images are representative of 3 mice per group. G The mRNA levels of TGF-β1, α-SMA, Col1α1 and FN with or without TPLR treatment by qPCR (n = 6). ###P < 0.001, ####P < 0.0001 vs. normal group; *P < 0.05, **P < 0.01, vs. model group

Full size image

Discussion

Liver fibrosis is caused by various chronic liver diseases, and eventually progress to cirrhosis and even HCC, and the activated HSCs plays a key role in the development of liver fibrosis [44]. Clinical and experimental studies have demonstrated that removal of the etiologic stimuli of liver injury results in regression of liver fibrosis and disappearance of activated HSCs by apoptosis [45], and it be beneficial to investigate compounds or extracts which promote the apoptosis of activated HSCs. Fortunately, TPLR treatment was able to significantly inhibited HSC activation in vitro, as evidenced by its inhibitory effect on the expression of the activation marker a-SMA, collagen as well as other fibrotic genes. Moreover, Caspases (cysteine-aspartic proteases) are proteolytic enzymes largely known for their role in controlling cell death, once initiator caspases are activated through the extrinsic or intrinsic apoptosis pathways, they mediate activation of effector caspases-3 [46]. In this study, TPLR (200 μg/mL) significantly increased the expression of caspase-10, -8 and -3 at 12 h after HSCs activation with TGF-β1, the result suggested TPLR promoted apoptosis through an extrinsic apoptotic pathway under TGF-β1 stimulation [47]. However, these apoptosis proteins were scarcely up-regulated with TPLR direct intervention for 12 h; surprisingly, after TPLR treatment 48 h, the expression of caspase-3, -8, -10 and -9 were significantly increased, since caspase-9 plays a central role of intrinsic apoptotic pathway [48, 49], the result suggested the apoptosis of HSCs were both in intrinsic and extrinsic apoptotic pathway with TPLR direct intervention. Altogether, our results suggested that TPLR promoted apoptosis of HSCs.

TGF-β1 also activates the downstream signaling pathway, promotes the phosphorylation of Smad2/3, and binds to Smad4 in the nucleus to mediate fibrosis, which is negatively regulated by the Smad7 degradation pathway [41]. Our research proved that TPLR inhibited TGF-β1 signaling pathway by downregulating the Smad2/3 and Smad4 in a dose-dependent manner. Importantly, Smad7 inhibits TGF-β1 signaling pathway and mediates apoptosis in various cells, recent studies have confirmed that upregulation Smad7 promoted the apoptosis of podocytes [50], ovarian granulosa cells [51] and HSCs [52]. Consistent with these studies, we also found that TPLR significantly increased the expression of Smad7 in vivo and in vitro, it suggested that TPLR ameliorates hepatic fibrosis and promoted the apoptosis of HSCs mainly depended on the TGF-β/Smad signaling pathway.

To investigate the effective chemicals in TPLR extract, the chemical constituents of TPLR were identified with an UPLC-TOF-MSn spectra method. In this study, verbascoside was found to be the main compounds of TPLR extract since the area of the compound accounts for 25.6% in the total ion current profile, meanwhile, several studies revealed that verbascoside promoted apoptosis in a variety of tumor cells, such as such as oral squamous cells [53], human colorectal cancer [54], and glioblastoma [55], these results inferred that verbascoside would be one of the main bioactive compounds which was responsible for promoting apoptosis effect of TPLR. Interestingly, compared with the model group, we also found TPLR (200 mg/ml) down-regulated the expression of apoptosis regulatory proteins in liver which suggested that TPLR could protect mice from CCl4-induced liver steatosis (Additional file 1: Fig. S2) [56]. Furthermore, among the identified compounds in TPLR, luteolin was listed as the marker compound used for quality control during 1995–2000 in the Chinese pharmacopoeia [19], and many studies demonstrated that the compound exhibited antifibrotic effects by downregulation TGF-β/Smad signaling pathway in recent years [57, 58]. From the above mentioned, our study confirmed TPLR induced the apoptosis of HSCs via TGF-β/Smad signaling pathway against hepatic fibrosis.

Conclusion

In vitro and in vivo studies have shown that TPLR, a total polyphenolic glycoside extracted of L rotata, is the main active substance against hepatic fibrosis, which promotes the apoptosis of HSCs by TGF-β/Smad signaling pathway.

Availability of data and materials

The raw data for this article will be made available by the authors, without undue reservation.

Abbreviations

ECM:

extracellular matrix

HSCs:

Hepatic stellate cells

L. rotata :

Lamiophlomis rotate

TPLR:

Total polyphenolic glycosides of L. rotate

UPLC-Q/TOF/MSn :

Ultrahigh-performance liquid chromatography coupled with time-of-flight mass spectrometry

CCl4 :

Carbon tetrachloride

FN:

Fibronectin

α-SMA:

α-Smooth muscle actin

Col1α1:

Collagen I

HCC:

Hepatocellular carcinoma

TRAIL:

TNF-related apoptosis-inducing ligand

TGF-β:

Transforming growth factor-β

AST:

Serum aspartate aminotransferase

ALT:

Alanine aminotransferase

Hyp:

Hydroxyproline

DMEM:

Dulbecco’s modified Eagle’s medium

PMSF:

Phenylmethanesulfonyl fluoride

PVDF:

Polyvinylidene fluoride membranes

CMC-Na:

Sodium carboxymethylcellulose

HE:

Hematoxylin and eosin

IF:

Immunofluorescence

LSD:

Least significant difference

References

  1. Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14(3):181–94. https://doi.org/10.1038/nri3623.

    Article  CAS  PubMed  Google Scholar 

  2. Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015;61(3):1066–79. https://doi.org/10.1002/hep.27332.

    Article  PubMed  Google Scholar 

  3. Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17(5):306–21. https://doi.org/10.1038/nri.2017.11.

    Article  CAS  PubMed  Google Scholar 

  4. Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA. 2012;109(24):9448–53. https://doi.org/10.1073/pnas.1201840109.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Iwaisako K, Jiang C, Zhang M, Cong M, Moore-Morris TJ, Park TJ, et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci USA. 2014;111(32):E3297–305. https://doi.org/10.1073/pnas.1400062111.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kendall TJ, Hennedige S, Aucott RL, Hartland SN, Vernon MA, Benyon RC, et al. p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis. Hepatology. 2009;49(3):901–10. https://doi.org/10.1002/hep.22701.

    Article  CAS  PubMed  Google Scholar 

  7. Cheng C-F, Pan T-M. Ankaflavin and monascin induce apoptosis in activated hepatic stellate cells through suppression of the Akt/NF-κB/p38 signaling pathway. J Agric Food Chem. 2016;64(49):9326–34. https://doi.org/10.1021/acs.jafc.6b03700.

    Article  CAS  PubMed  Google Scholar 

  8. Wang C, Zhang F, Cao Y, Zhang M, Wang A, Xu M, et al. Etoposide induces apoptosis in activated human hepatic stellate cells via ER stress. Sci Rep. 2016;6:34330. https://doi.org/10.1038/srep34330.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Liu H-Y, Wang L-G, Dai L-Y, Feng F-M, Xiao YH. CaMK II/Ca2+ dependent endoplasmic reticulum stress mediates apoptosis of hepatic stellate cells stimulated by transforming growth factor beta 1. Int J Biol Macromol. 2021;172:321–9. https://doi.org/10.1016/j.ijbiomac.2021.01.071.

    Article  CAS  PubMed  Google Scholar 

  10. Sun X, Huang X, Zhu X, Liu L, Mo S, Wang H, et al. HBOA ameliorates CCl-incuded liver fibrosis through inhibiting TGF-β1/Smads, NF-κB and ERK signaling pathways. Biomed Pharmacother. 2019;115:108901. https://doi.org/10.1016/j.biopha.2019.108901.

    Article  CAS  PubMed  Google Scholar 

  11. Du X-S, Li H-D, Yang X-J, Li J-J, Xu J-J, Chen Y, et al. Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis. Int Immunopharmacol. 2019;75:105671. https://doi.org/10.1016/j.intimp.2019.05.056.

    Article  CAS  PubMed  Google Scholar 

  12. Liang B, Zhang X-X, Li R, Zhu Y-C, Tian X-J, Gu N. Guanxin V alleviates acute myocardial infarction by restraining oxidative stress damage, apoptosis, and fibrosis through the TGF-β1 signalling pathway. Phytomedicine. 2022;100:154077. https://doi.org/10.1016/j.phymed.2022.154077.

    Article  CAS  PubMed  Google Scholar 

  13. Chan Y-T, Wang N, Tan HY, Li S, Feng Y. Targeting hepatic stellate cells for the treatment of liver fibrosis by natural products: is it the dawning of a new era? Front Pharmacol. 2020;11:548. https://doi.org/10.3389/fphar.2020.00548.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Saile B, Matthes N, El Armouche H, Neubauer K, Ramadori G. The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells. Eur J Cell Biol. 2001;80(8):554–61. https://doi.org/10.1078/0171-9335-00182.

    Article  CAS  PubMed  Google Scholar 

  15. Xu F, Zhou D, Meng X, Wang X, Liu C, Huang C, et al. Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL. Int Immunopharmacol. 2016;32:76–86. https://doi.org/10.1016/j.intimp.2016.01.013.

    Article  CAS  PubMed  Google Scholar 

  16. Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C, et al. Praziquantel ameliorates CCl -induced liver fibrosis in mice by inhibiting TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate cells. Br J Pharmacol. 2019;176(24):4666–80. https://doi.org/10.1111/bph.14831.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Meng X-M, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–38. https://doi.org/10.1038/nrneph.2016.48.

    Article  CAS  PubMed  Google Scholar 

  18. Cui Z-H, Qin S-S, Zang E-H, Li C, Gao L, Li Q-C, et al. Traditional uses, phytochemistry, pharmacology and toxicology of Lamiophlomis rotata (Benth.) Kudo: a review. RSC Adv. 2020;10(19):11463–74. https://doi.org/10.1039/d0ra01050b.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Li Y, Li F, Zheng T-t, Shi L, Zhang Z-g, Niu T-m, et al. Lamiophlomis herba: a comprehensive overview of its chemical constituents, pharmacology, clinical applications, and quality control. Biomed Pharmacother. 2021;144:112299. https://doi.org/10.1016/j.biopha.2021.112299.

    Article  CAS  PubMed  Google Scholar 

  20. Wu L, Li L, Wang M, Shan C, Cui X, Wang J, et al. Target and non-target identification of chemical components in Lamiophlomis rotata by liquid chromatography/quadrupole time-of-flight mass spectrometry using a three-step protocol. Rapid Commun Mass Spectrom. 2016;30(19):2145–54. https://doi.org/10.1002/rcm.7695.

    Article  CAS  PubMed  Google Scholar 

  21. Yang H, Zhang Y, Tan W, Ma L, et al. Anti-fibrosis effects of Duyiwei Granule on hepatic fibrosis in rats. Shanghai J Tradit Chin Med. 2010;44(2):64–7. https://doi.org/10.16305/j.1007-1334.2010.02.023.

    Article  Google Scholar 

  22. Pan Z. inventor. The application of total iridoids glycosides in Lamiophlomis rotata on preparation of wound healing nature medicine. Patent, C.N.108159114A. 2018; (in Chinese).

  23. Morikawa T, Pan Y, Ninomiya K, Imura K, Matsuda H, Yoshikawa M, et al. Acylated phenylethanoid oligoglycosides with hepatoprotective activity from the desert plant Cistanche tubulosa. Bioorg Med Chem. 2010;18(5):1882–90. https://doi.org/10.1016/j.bmc.2010.01.047.

    Article  CAS  PubMed  Google Scholar 

  24. Zhang Y, Miao H, Yan H, Sheng Y, Ji L. Hepatoprotective effect of Forsythiae Fructus water extract against carbon tetrachloride-induced liver fibrosis in mice. J Ethno-pharmacol. 2018;218:27–34. https://doi.org/10.1016/j.jep.2018.02.033.

    Article  CAS  Google Scholar 

  25. Zhang C, Zhou J, Yang J, Li C, Ma J, Zhang D, et al. Two new phenylpropanoid glycosides from the aerial parts of Lespedeza cuneata. Acta Pharm Sin B. 2016;6(6):564–7. https://doi.org/10.1016/j.apsb.2016.05.009.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ruan X, Zhan L-m, Gao X-x, Yan L-y, Zhang H, Zhu Z-y, et al. Separation and purification of flavonoid from Taxus remainder extracts free of taxoids using polystyrene and polyamide resin. J Sep Sci. 2013;36(12):1925–34. https://doi.org/10.1002/jssc.201201189.

    Article  CAS  PubMed  Google Scholar 

  27. Wang D, Li R, Wei S, Gao S, Xu Z, Liu H, et al. Metabolomics combined with network pharmacology exploration reveals the modulatory properties of extract in the treatment of liver fibrosis. Chin Med. 2019;14:30. https://doi.org/10.1186/s13020-019-0251-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fan W, Liu T, Chen W, Hammad S, Longerich T, Hausser I, et al. ECM1 prevents activation of transforming growth factor β, hepatic stellate cells, and fibrogenesis in mice. Gastroenterology. 2019;157(5):1352–67. https://doi.org/10.1053/j.gastro.2019.07.036.

    Article  CAS  PubMed  Google Scholar 

  29. Gan J, Liu C, Li H, Wang S, Wang Z, Kang Z, et al. Accelerated wound healing in diabetes by reprogramming the macrophages with particle-induced clustering of the mannose receptors. Biomaterials. 2019;219:119340. https://doi.org/10.1016/j.biomaterials.2019.119340.

    Article  CAS  PubMed  Google Scholar 

  30. Hou Y, Zhang Y, Jiang S, Xie N, Zhang Y, Meng X, et al. Salidroside intensifies mitochondrial function of CoCl-damaged HT22 cells by stimulating PI3K-AKT-MAPK signaling pathway. Phytomedicine. 2022;109:154568. https://doi.org/10.1016/j.phymed.2022.154568.

    Article  CAS  PubMed  Google Scholar 

  31. Yao C, Cheng X, Guo X, Lu X, Bu F, Xu Y. NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis. Cancer Cell Int. 2020;20:463. https://doi.org/10.1186/s12935-020-01505-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hu J-P, Zhang R, Tang M, Li Y-L, Xun L-T, Shi Z-Z, et al. Loureirin B inhibits the proliferation of hepatic stellate cells and the Wnt/β-catenin signaling pathway by regulating miR-148-3p. Cell Mol Biol Lett. 2018;23:35. https://doi.org/10.1186/s11658-018-0098-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Zheng H, Wang X, Zhang Y, Chen L, Hua L, Xu W. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-kappaB pathway and promoting HSC apoptosis. J Ethno-pharmacol. 2019;244:111856. https://doi.org/10.1016/j.jep.2019.111856.

    Article  CAS  Google Scholar 

  34. Wu J, Zhang D, Zhu B, Wang S, Xu Y, Zhang C, et al. Rubus chingii Hu. unripe fruits extract ameliorates carbon tetrachloride-induced liver fibrosis and improves the associated gut microbiota imbalance. Chin Med. 2022;17(1):56. https://doi.org/10.1186/s13020-022-00607-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Yang L, Bi L, Jin L, Wang Y, Li Y, Li Z, et al. Geniposide ameliorates liver fibrosis through reducing oxidative stress and inflammatory respose, inhibiting apoptosis and modulating overall metabolism. Front Pharmacol. 2021;12:772635. https://doi.org/10.3389/fphar.2021.772635.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Graça D, Louro H, Santos J, Dias K, Almeida AJ, Gonçalves L, et al. Toxicity screening of a novel poly(methylmethacrylate)-Eudragit nanocarrier on L929 fibroblasts. Toxicol Lett. 2017;276:129–37. https://doi.org/10.1016/j.toxlet.2017.05.017.

    Article  CAS  PubMed  Google Scholar 

  37. Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: concept to treatment. J Hepatol. 2015;62(1 Suppl):S15–24. https://doi.org/10.1016/j.jhep.2015.02.039.

    Article  CAS  PubMed  Google Scholar 

  38. Xu L, Hui AY, Albanis E, Arthur MJ, O’Byrne SM, Blaner WS, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut. 2005;54(1):142–51. https://doi.org/10.1016/j.jhep.2015.02.039.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res. 2000;41(6):882–93. https://doi.org/10.1136/gut.2004.042127.

    Article  CAS  PubMed  Google Scholar 

  40. Zhang Y, Alexander PB, Wang XF. TGF-β family signaling in the control of cell proliferation and survival. Cold Spring Harb Perspect Biol. 2017. https://doi.org/10.1101/cshperspect.a022145.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Meynier S, Rieux-Laucat F. FAS and RAS related apoptosis defects: from autoimmunity to leukemia. Immunol Rev. 2019;287(1):50–61. https://doi.org/10.1111/imr.12720.

    Article  CAS  PubMed  Google Scholar 

  42. Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, Ehnert S, et al. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology. 2008;135(2):642–59. https://doi.org/10.1053/j.gastro.2008.04.038.

    Article  CAS  PubMed  Google Scholar 

  43. Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587(7835):555–66. https://doi.org/10.1038/s41586-020-2938-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823. https://doi.org/10.1038/ncomms3823.

    Article  CAS  PubMed  Google Scholar 

  45. Ding D, Chen L-L, Zhai Y-Z, Hou C-J, Tao L-L, Lu S-H, et al. Trichostatin A inhibits the activation of Hepatic stellate cells by Increasing C/EBP-α Acetylation in vivo and in vitro. Sci Rep. 2018;8(1):4395. https://doi.org/10.1038/s41598-018-22662-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Shalini S, Dorstyn L, Dawar S, Kumar S. Old, new and emerging functions of caspases. Cell Death Differ. 2015;22(4):526–39. https://doi.org/10.1038/cdd.2014.216.

    Article  CAS  PubMed  Google Scholar 

  47. Johnson A, DiPietro LA. Apoptosis and angiogenesis: an evolving mechanism for fibrosis. FASEB J. 2013;27(10):3893–901. https://doi.org/10.1096/fj.12-214189.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. An H-K, Chung KM, Park H, Hong J, Gim J-E, Choi H, et al. CASP9 (caspase 9) is essential for autophagosome maturation through regulation of mitochondrial homeostasis. Autophagy. 2020;16(9):1598–617. https://doi.org/10.1080/15548627.2019.1695398.

    Article  PubMed  Google Scholar 

  49. de Oliveira da Silva B, Ramos LF, Moraes KCM. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis. Cell Biol Int. 2017;41(9):946–59. https://doi.org/10.1002/cbin.10790.

    Article  CAS  PubMed  Google Scholar 

  50. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest. 2001;108(6):807–16. https://doi.org/10.1172/JCI12367.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Yao W, Pan Z, Du X, Zhang J, Li Q. miR-181b-induced SMAD7 downregulation controls granulosa cell apoptosis through TGF-β signaling by interacting with the TGFBR1 promoter. J Cell Physiol. 2018;233(9):6807–21. https://doi.org/10.1002/jcp.26431.

    Article  CAS  PubMed  Google Scholar 

  52. He H, Dai J, Feng J, He Q, Chen X, Dai W, et al. FBXO31 modulates activation of hepatic stellate cells and liver fibrogenesis by promoting ubiquitination of Smad7. J Cell Biochem. 2019;121(8–9):3711–9. https://doi.org/10.1002/jcb.29528.

    Article  CAS  PubMed  Google Scholar 

  53. Zhang Y, Yuan Y, Wu H, Xie Z, Wu Y, Song X, et al. Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma. Int J Cancer. 2018;143(4):980–91. https://doi.org/10.1002/ijc.31378.

    Article  CAS  PubMed  Google Scholar 

  54. Zhou L, Feng Y, Jin Y, Liu X, Sui H, Chai N, et al. Verbascoside promotes apoptosis by regulating HIPK2-p53 signaling in human colorectal cancer. BMC Cancer. 2014;14:747. https://doi.org/10.1186/1471-2407-14-747.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Wang H, Feng J, Ao F, Tang Y, Xu P, Wang M, et al. Tumor-derived exosomal microRNA-7–5p enhanced by verbascoside inhibits biological behaviors of glioblastoma. Mol Ther Oncolytics. 2021;20:569–82. https://doi.org/10.1016/j.omto.2020.12.006.

    Article  CAS  PubMed  Google Scholar 

  56. Tian H, Liu L, Li Z, Liu W, Sun Z, Xu Y, et al. Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats. J Ethnopharmacol. 2019;232:227–35. https://doi.org/10.1016/j.jep.2018.11.027.

    Article  CAS  PubMed  Google Scholar 

  57. Li J, Li X, Xu W, Wang S, Hu Z, Zhang Q, et al. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways. Liver Int. 2015;35(4):1222–33. https://doi.org/10.1111/liv.12638.

    Article  CAS  PubMed  Google Scholar 

  58. Domitrović R, Jakovac H, Tomac J, Sain I. Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin. Toxicol Appl Pharmacol. 2009;241(3):311–21. https://doi.org/10.1016/j.taap.2009.09.001.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank all the staff members of the Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, Chongqing, China.

Funding

This work was supported by the National Natural Science Foundation of China (grant number: 81973567, 82004168, 81973573), Natural Science Foundation of Chongqing (grant number: cstc2019jcyj-msxmX0180), Program of Chongqing Health Commission (grant number: 2019ZY3503).

Author information

Author notes

  1. Guoguo Wan and Zhiwei Chen are co-first authors and contributed equally to this work

Authors and Affiliations

  1. Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, College of Traditional Chinese Medicine, Chongqing Medical University, No.1, Yixueyuan Road, Yuzhong District, Chongqing, 400016, People’s Republic of China

    Guoguo Wan, Zhiwei Chen, Lei Lei, Xiaoyu Geng, Congwen Yang, Wenfu Cao & Zheng Pan

  2. Centre for Academic Inheritance and Innovation of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611130, China

    Yi Zhang

Authors
  1. Guoguo Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhiwei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lei Lei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaoyu Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Congwen Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wenfu Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zheng Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ZP conceived, designed, and supervised the research project. GW: investigation, methodology, writing an original draft. ZC: methodology, visualization and project administration. LL: helped perform the experiments. CY: helped perform the experiments. WC: helped perform the experiments. XG: collected and analyzed the data. The herbs were authenticated by Professor YZ. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Zheng Pan.

Ethics declarations

Ethics approval and consent to participate

All animal experiments were approved by the institutional animal care and committee of Chongqing Medical University (Ethics number: 2021053).

Consent for publication

We declare that the Publisher has the author’s permission to publish the relevant contribution.

Competing interests

The authors declare that there are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Table S1. List of primers in PCR amplification. Fig. S1. The effect of TPLR on the cell cycle of LX-2 cells. Fig. S2. TPLR downregulated apoptosis-related proteins in mice. Fig. S4. Original images of Western Blot.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wan, G., Chen, Z., Lei, L. et al. The total polyphenolic glycoside extract of Lamiophlomis rotata ameliorates hepatic fibrosis through apoptosis by TGF-β/Smad signaling pathway. Chin Med 18, 20 (2023). https://doi.org/10.1186/s13020-023-00723-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13020-023-00723-x

Keywords

Chinese Medicine

ISSN: 1749-8546

Contact us